DOI:
10.1055/s-00000020
Geburtshilfe und Frauenheilkunde
LinksClose Window
References
Modi S, Saura C, Yamashita T. et al. DESTINY-Breast01 Investigators.
Trastuzumab Deruxtecan in Previously Treated HER2-Positive Breast Cancer.
N Engl J Med 2020;
382: 610-621
Access:
Access:
We do not assume any responsibility for the contents of the web pages of other providers.